000 01633 a2200433 4500
005 20250515204911.0
264 0 _c20100507
008 201005s 0 0 eng d
022 _a1873-5967
024 7 _a10.1016/S1386-6532(09)00540-X
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMeijer, C J L M
245 0 0 _aValidation of high-risk HPV tests for primary cervical screening.
_h[electronic resource]
260 _bJournal of clinical virology : the official publication of the Pan American Society for Clinical Virology
_cNov 2009
300 _aS1-4 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAlphapapillomavirus
_xgenetics
650 0 4 _aCervix Uteri
_xpathology
650 0 4 _aClinical Laboratory Techniques
650 0 4 _aClinical Trials as Topic
650 0 4 _aDNA, Viral
_xgenetics
650 0 4 _aFemale
650 0 4 _aGuidelines as Topic
650 0 4 _aHumans
650 0 4 _aMass Screening
_xmethods
650 0 4 _aPapillomavirus Infections
_xcomplications
650 0 4 _aRisk
650 0 4 _aSensitivity and Specificity
650 0 4 _aUterine Cervical Neoplasms
_xdiagnosis
650 0 4 _aVaginal Smears
650 0 4 _aValidation Studies as Topic
650 0 4 _aUterine Cervical Dysplasia
_xdiagnosis
700 1 _aBerkhof, H
700 1 _aHeideman, D A M
700 1 _aHesselink, A T
700 1 _aSnijders, P J F
773 0 _tJournal of clinical virology : the official publication of the Pan American Society for Clinical Virology
_gvol. 46 Suppl 3
_gp. S1-4
856 4 0 _uhttps://doi.org/10.1016/S1386-6532(09)00540-X
_zAvailable from publisher's website
999 _c19501004
_d19501004